# Lineage Cell Therapeutics, Inc.: Form 8-K, filed May 5, 2021

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2021-05-05
- Accepted by EDGAR: May 5, 2021, 17:00 ET
- Period: 2021-05-04
- Accession: 0001493152-21-010533
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315221010533/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315221010533/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315221010533/form8-k.htm

Filed May 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-010533. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
